Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
:TWST
Total Valuation
Twist Bioscience has a market cap or net worth of $1.85B. The enterprise value is ―.
Market Cap$1.85B
Enterprise Value―
Share Statistics
Twist Bioscience has 59,916,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,916,140
Owned by Insiders3.23%
Owned by Institutions0.09%
Financial Efficiency
Twist Bioscience’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -38.65%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-38.65%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee339.08K
Profits Per Employee-226.14K
Employee Count923
Asset Turnover0.51
Inventory Turnover7.46
Valuation Ratios
The current PE Ratio of Twist Bioscience is -12.56. Twist Bioscience’s PEG ratio is -2.67.
PE Ratio-12.56
PS Ratio0.00
PB Ratio4.44
Price to Fair Value5.55
Price to FCF-29.86
Price to Operating Cash Flow-34.85
PEG Ratio-2.67
Income Statement
In the last 12 months, Twist Bioscience had revenue of 312.97M and earned -208.73M in profits. Earnings per share was -3.60.
Revenue312.97M
Gross Profit133.35M
Operating Income-220.83M
Pretax Income-208.17M
Net Income-208.73M
EBITDA-176.71M
Earnings Per Share (EPS)-3.60
Cash Flow
In the last 12 months, operating cash flow was -56.11M and capital expenditures -9.38M, giving a free cash flow of -65.49M billion.
Operating Cash Flow-56.11M
Free Cash Flow-65.49M
Free Cash Flow per Share-1.09
Dividends & Yields
Twist Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.03
52-Week Price Change-35.02%
50-Day Moving Average38.70
200-Day Moving Average44.20
Relative Strength Index (RSI)32.68
Average Volume (3m)1.32M
Important Dates
Twist Bioscience upcoming earnings date is Aug 1, 2025, TBA Not Confirmed.
Last Earnings DateMay 5, 2025
Next Earnings DateAug 1, 2025
Ex-Dividend Date―
Financial Position
Twist Bioscience as a current ratio of 4.88, with Debt / Equity ratio of 18.25%
Current Ratio4.88
Quick Ratio4.54
Debt to Market Cap<0.01
Net Debt to EBITDA0.80
Interest Coverage Ratio-7.61K
Taxes
In the past 12 months, Twist Bioscience has paid 560.00K in taxes.
Income Tax560.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Twist Bioscience EV to EBITDA ratio is -14.03, with an EV/FCF ratio of -35.85.
EV to Sales7.92
EV to EBITDA-14.03
EV to Free Cash Flow-35.85
EV to Operating Cash Flow-38.69
Balance Sheet
Twist Bioscience has $257.15M in cash and marketable securities with $80.30M in debt, giving a net cash position of -$176.85M billion.
Cash & Marketable Securities$257.15M
Total Debt$80.30M
Net Cash-$176.85M
Net Cash Per Share-$2.95
Tangible Book Value Per Share$6.42
Margins
Gross margin is 46.70%, with operating margin of -70.56%, and net profit margin of -66.69%.
Gross Margin46.70%
Operating Margin-70.56%
Pretax Margin-66.51%
Net Profit Margin-66.69%
EBITDA Margin-56.46%
EBIT Margin-66.50%
Analyst Forecast
The average price target for Twist Bioscience is $47.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$47.75
Price Target Upside54.93% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast25.30%
EPS Growth Forecast2.75%